Obstructive sleep apnoea: a diabetologist’s perspective
DOI:
https://doi.org/10.15277/bjd.2016.088Keywords:
obstructive sleep apnoea, type 2 diabetes, hypertension, cardiovascular disease, hyperlipidaemia, quality of lifeAbstract
Obstructive sleep apnoea (OSA) is very common in patients with type 2 diabetes (T2D), which is unsurprising given that obesity is a major risk factor for both conditions. OSA has been associated with impaired quality of life, many cardiovascular disease (CVD) risk factors and cardiovascular disease in general. Continuous positive airway pressure treatment has beneficial impacts on CVD risk factors and CVD. However, the true impact of OSA in patients with T2D remains unclear. The International Diabetes Federation recommended routine screening for OSA in patients with T2D, but two-thirds of diabetes healthcare professionals were unaware of these recommendations. The aim of this review is to attempt to answer the following questions. Is OSA diagnosis and treatment important in patients with T2D and why? What is the relevance of OSA to the practising diabetologist?References
Punjabi NM, Beamer BA. Alterations in glucose disposal in sleep-disordered breathing. Am J Respir Crit Care Med 2009;179:235–40. http://dx.doi.org/10.1164/rccm.200809-1392OC
Polotsky VY, Patil SP, Savransky V, et al. Obstructive sleep apnea, insulin resistance, and steatohepatitis in severe obesity. Am J Respir Crit Care Med 2009;179:228–34. http://dx.doi.org/10.1164/rccm.200804-608OC
Bhushan B, Misra A, Guleria R. Obstructive sleep apnea is independently associated with the metabolic syndrome in obese Asian Indians in northern India. Metab Syndr Relat Disord 2010;8:431–5.
Hermans MP, Ahn SA, Rousseau MF. Cardiometabolic phenotype and UKPDS risk in male type 2 diabetic patients with obstructive sleep apnoea. Diabetes & Metabolic Syndrome: Clinical Research & Reviews 2009;3:50–4.
Hermans MP, Ahn SA, Mahadeb YP, Rousseau MF. Sleep apnoea syndrome and 10-year cardiovascular risk in females with type 2 diabetes: relationship with insulin secretion and insulin resistance. Diabetes Metab Res Rev 2013;29:227–34. http://dx.doi.org/10.1002/dmrr.2387
Gruber A, Horwood F, Sithole J, Ali NJ, Idris I. Obstructive sleep apnoea is independently associated with the metabolic syndrome but not insulin resistance state. Cardiovasc Diabetol 2006;5:22.
Sharma SK, Kumpawat S, Goel A, Banga A, Ramakrishnan L, Chaturvedi P. Obesity, and not obstructive sleep apnea, is responsible for metabolic abnormalities in a cohort with sleep-disordered breathing. Sleep Med 2007;8:12–17.
Onat A, Hergenc G, Uyarel H, et al. Obstructive sleep apnea syndrome is associated with metabolic syndrome rather than insulin resistance. Sleep Breath 2007;11:23–30.
Barcelo A, Barbe F, de la Pena M, et al. Insulin resistance and daytime sleepiness in patients with sleep apnoea. Thorax 2008;63:946–50. http://dx.doi.org/10.1136/thx.2007.093740
Nena E, Steiropoulos P, Papanas N, et al. Sleepiness as a marker of glucose deregulation in obstructive sleep apnea. Sleep Breath 2012;16:181–6. http://dx.doi.org/10.1007/s11325-010-0472-y
Pamidi S, Wroblewski K, Broussard J, et al. Obstructive sleep apnea in young lean men: impact on insulin sensitivity and secretion. Diabetes Care 2012;35:2384–9. http://dx.doi.org/10.2337/dc12-0841
Lin QC, Zhang XB, Chen GP, Huang DY, Din HB, Tang AZ. Obstructive sleep apnea syndrome is associated with some components of metabolic syndrome in nonobese adults. Sleep Breath 2012;16:571–8. http://dx.doi.org/10.1007/s11325-011-0544-7
Duarte FH, Jallad RS, Amaro AC, Drager LF, Lorenzi-Filho G, Bronstein MD. The impact of sleep apnea treatment on carbohydrate metabolism in patients with acromegaly. Pituitary 2012;16:341–50. http://dx.doi.org/ 10.1007/s11102-012-0430-8
Lindberg E, Theorell-Haglöw J, Svensson M, Gislason T, Berne C, Janson C. Sleep apnea and glucose metabolism: a long-term follow-up in a community-based sample. Chest 2012;142:935–42.
Punjabi NM, Beamer BA. Alterations in glucose disposal in sleep-disordered breathing. Am J Respir Crit Care Med 2009;179:235–40. http://dx.doi.org/10.1164/rccm.200809-1392OC
Mishra P, Nugent C, Afendy A, et al. Apnoeic-hypopnoeic episodes during obstructive sleep apnoea are associated with histological nonalcoholic steatohepatitis. Liver Int 2008;28:1080–6.
Elmasry A, Janson C, Lindberg E, Gislason T, Tageldin MA, Boman G. The role of habitual snoring and obesity in the development of diabetes: a 10-year follow-up study in a male population. J Intern Med 2000; 248:13–20.
Reichmuth KJ, Austin D, Skatrud JB, Young T. Association of sleep apnea and type II diabetes: a population-based study. Am J Respir Crit Care Med 2005;172:1590–5.
Botros N, Concato J, Mohsenin V, Selim B, Doctor K, Yaggi HK. Obstructive sleep apnea as a risk factor for type 2 diabetes. Am J Med 2009;122:1122–7. http://dx.doi.org/10.1016/j.amjmed.2009.04.026
Celen YT, Hedner J, Carlson J, Peker Y. Impact of gender on incident diabetes mellitus in obstructive sleep apnea: a 16-year follow-up. J Clin Sleep Med 2010;6:244–50.
Wang X, Bi Y, Zhang Q, Pan F. Obstructive sleep apnoea and the risk of type 2 diabetes: a meta-analysis of prospective cohort studies. Respirology 2013;18:140–6. http://dx.doi.org/10.1111/j.1440-1843. 2012.02267.x
Pamidi S, Wroblewski K, Stepien M, et al. Eight hours of nightly CPAP treatment of obstructive sleep apnea improves glucose metabolism in prediabetes: a randomized controlled trial. Am J Respir Crit Care Med 2015;192:96–105. http://dx.doi.org/10.1164/rccm.201408-1564OC
Papanas N, Steiropoulos P, Nena E, et al. HbA1c is associated with severity of obstructive sleep apnea hypopnea syndrome in nondiabetic men. Vasc Health Risk Manag 2009;5:751–6.
Pillai A, Warren G, Gunathilake W, Idris I. Effects of sleep apnea severity on glycemic control in patients with type 2 diabetes prior to continuous positive airway pressure treatment. Diabetes Technol Ther 2011;13:945–9.
Aronsohn RS, Whitmore H, Van Cauter E, Tasali E. Impact of untreated obstructive sleep apnea on glucose control in type 2 diabetes. Am J Respir Crit Care Med 2010;181:507–13. http://dx.doi.org/10.1164/rccm.200909-1423OC
Tamura A, Kawano Y, Watanabe T, Kadota J. Obstructive sleep apnea increases hemoglobin A1c levels regardless of glucose tolerance status. Sleep Med 2012;13:1050–5. http://dx.doi.org/10.1016/j.sleep.2012.04.007
Einhorn D, Stewart DA, Erman MK, Gordon N, Philis-Tsimikas A, Casal E. Prevalence of sleep apnea in a population of adults with type 2 diabetes mellitus. Endocr Pract 2007;13:355–62.
Pamidi S, Tasali E. Obstructive sleep apnea and type 2 diabetes: is there a link? Frontiers Neurol 2012;3:126.
Peppard PE, Young T, Palta M, Skatrud J. Prospective study of the association between sleep-disordered breathing and hypertension. N Engl J Med 2000;342:1378–84.
Hla KM, Young T, Finn L, Peppard PE, Szklo-Coxe M, Stubbs M. Longitudinal association of sleep-disordered breathing and nondipping of nocturnal blood pressure in the Wisconsin Sleep Cohort Study. Sleep 2008;31:795–800.
Ayala DE, Moyá A, Crespo JJ, et al. Circadian pattern of ambulatory blood pressure in hypertensive patients with and without type 2 diabetes. Chronobiol Int 2012;30:99–115. http://dx.doi.org/10.3109/07420528.2012.701489
Adedayo A, Olafiranye O, Smith D, et al. Obstructive sleep apnea and dyslipidemia: evidence and underlying mechanism. Sleep Breath 2014;18:13–18. http://dx.doi.org/10.1007/s11325-012-0760-9
Nadeem R, Singh M, Nida M, et al. Effect of obstructive sleep apnea hypopnea syndrome on lipid profile: a meta-regression analysis. J Clin Sleep Med 2014;10:475–89. http://dx.doi.org/10.5664/jcsm.3690
Lin QC, Zhang XB, Chen GP, Huang DY, Din HB, Tang AZ. Obstructive sleep apnea syndrome is associated with some components of metabolic syndrome in nonobese adults. Sleep Breath 2012;16:571–8. http://dx.doi.org/10.1007/s11325-011-0544-7
Turmel J, Sériès F, Boulet LP, et al. Relationship between atherosclerosis and the sleep apnea syndrome: an intravascular ultrasound study. Int J Cardiol 2009;132:203–09.
Kent BD, Garvey JF, Ryan S, Nolan G, Dodd JD, McNicholas WT. Severity of obstructive sleep apnoea predicts coronary artery plaque burden: a coronary CT angiography study. Eur Respir J 2013;42:1263–70. http://dx.doi.org/10.1183/09031936.00094812
Kuniyoshi FH, Garcia-Touchard A, Gami AS, et al. Day-night variation of acute myocardial infarction in obstructive sleep apnea. J Am Coll Cardiol 2008;52:343–6. http://dx.doi.org/10.1016/j.jacc.2008.04.027
Peker Y, Hedner J, Norum J, Kraiczi H, Carlson J. Increased incidence of cardiovascular disease in middle-aged men with obstructive sleep apnea: a 7-year follow-up. Am J Respir Crit Care Med 2002;166:159–65.
Marin JM, Carrizo SJ, Vicente E, Agusti AG. Long-term cardiovascular outcomes in men with obstructive sleep apnoea-hypopnoea with or without treatment with continuous positive airway pressure: an observational study. The Lancet 2005;365:1046–53.
Yaggi HK, Concato J, Kernan WN, Lichtman JH, Brass LM, Mohsenin V. Obstructive sleep apnea as a risk factor for stroke and death. N Engl J Med 2005;353:2034–41.
Ou Q, Chen YC, Zhuo SQ, et al. Continuous positive airway pressure treatment reduces mortality in elderly patients with moderate to severe obstructive severe sleep apnea: a cohort study. PLoS One 2015; 10:e0127775. http://dx.doi.org/10.1371/journal.pone.0127775
Molnar MZ, Mucsi I, Novak M, et al. Association of incident obstructive sleep apnoea with outcomes in a large cohort of US veterans. Thorax 2015;70:888–95. http://dx.doi.org/10.1136/thoraxjnl-2015-206970
Gottlieb DJ, Yenokyan G, Newman AB, et al. Prospective study of obstructive sleep apnea and incident coronary heart disease and heart failure: The Sleep Heart Health Study. Circulation 2010;122:352–60. http://dx.doi.org/10.1161/CIRCULATIONAHA.109.901801
Redline S, Yenokyan G, Gottlieb DJ, et al. Obstructive sleep apnea- hypopnea and incident stroke. Am J Respir Crit Care Med 2010;182: 269–77. http://dx.doi.org/10.1164/rccm.200911-1746OC
Campos-Rodriguez F, Martinez-Garcia MA, Reyes-Nuñez N, Caballero-Martinez I, Catalan-Serra P, Almeida-Gonzalez CV. Role of sleep apnea and continuous positive airway pressure therapy in the incidence of stroke or coronary heart disease in women. Am J Respir Crit Care Med 2014;189:1544–50. http://dx.doi.org/10.1164/rccm.201311-2012OC
Rice TB, Foster GD, Sanders MH, et al. The relationship between obstructive sleep apnea and self-reported stroke or coronary heart disease in overweight and obese adults with type 2 diabetes mellitus. Sleep 2012;35:1293–8.
Seicean S, Strohl KP, Seicean A, Gibby C, Marwick TH. Sleep disordered breathing as a risk of cardiac events in subjects with diabetes mellitus and normal exercise echocardiographic findings. Am J Cardiol 2013;111:1214–20. http://dx.doi.org/10.1016/j.amjcard.2012.12.053
Shiba T, Maeno T, Saishin Y, Hori Y, Takahashi M. Nocturnal intermittent serious hypoxia and reoxygenation in proliferative diabetic retinopathy cases. Am J Ophthalmol 2010;149:959–63.
http://dx.doi.org/10.1016/j.ajo.2010.01.006
West SD, Groves DC, Lipinski HJ, et al. The prevalence of retinopathy in men with type 2 diabetes and obstructive sleep apnoea. Diabet Med 2010;27:423–30. http://dx.doi.org/10.1111/j.1464-5491.2010.02962.x
Tahrani AA, Dodson P, Ali A, et al. Obstructive sleep apnoea is associated with sight threatening retinopathy and predicts the development of preproliferative and proliferative retinopathy in patients with type 2 diabetes: a longitudinal analysis. Eur J Ophthalmol 2013;23:449.
Furukawa S, Saito I, Yamamoto S, et al. Nocturnal intermittent hypoxia as an associated risk factor for microalbuminuria in Japanese patients with type 2 diabetes mellitus. Eur J Endocrinol 2013;169:239–46. http://dx.doi.org/10.1530/EJE-13-0086
Tahrani AA, Ali A, Raymond NT, et al. Obstructive sleep apnea and diabetic nephropathy: a cohort study. Diabetes Care 2013;36:3718–25. http://dx.doi.org/10.2337/dc13-0450
Altaf QA, Ali A, Piya MK, Raymond NT, Tahrani AA. The relationship between obstructive sleep apnea and intra-epidermal nerve fiber density, PARP activation and foot ulceration in patients with type 2 diabetes. J Diabetes Complications 2016;30(7):1315-20. http://dx.doi.org/10.1016/j.jdiacomp.2016.05.025.
Appleton S, Vakulin A, McEvoy RD, et al. Undiagnosed obstructive sleep apnea is independently associated with reductions in quality of life in middle-aged, but not elderly men of a population cohort. Sleep Breath 2015;19:1309–16. http://dx.doi.org/10.1007/s11325-015-1171-5
D'Ambrosio C, Bowman T, Mohsenin V. Quality of life in patients with obstructive sleep apnea: effect of nasal continuous positive airway pressureGÇöa prospective study. Chest 1999;115:123–9.
Horne JA, Reyner LA. Sleep related vehicle accidents. BMJ 1995;310: 565–7.
Young T, Blustein J, Finn L, Palta M. Sleep-disordered breathing and motor vehicle accidents in a population-based sample of employed adults. Sleep 1997;20:608–13.
Karimi M, Hedner J, Häbel H, Nerman O, Grote L. A sleep apnea-related risk of motor vehicle accidents is reduced by continuous positive airway pressure: Swedish Traffic Accident Registry Data. Sleep 2014;38:341–9. doi: 10.5665/sleep.4486
Hoyos CM, Melehan KL, Phillips CL, Grunstein RR, Liu PY. To ED or not to ED: Is erectile dysfunction in obstructive sleep apnea related to endothelial dysfunction? Sleep Med Rev 2015;20:5–14 http://dx.doi.org/10.1016/j.smrv.2014.03.004
Li F, Feng Q, Zhang X, Liu Q. [Treatment for erectile dysfunction patients with obstructive sleep apnea syndrome by nasal continual positive airway pressure]. Zhonghua nan ke xue (National Journal of Andrology) 2004;10:355–7.
Perimenis P, Karkoulias K, Markou S, et al. Erectile dysfunction in men with obstructive sleep apnea syndrome: a randomized study of the efficacy of sildenafil and continuous positive airway pressure. Int J Impotence Res 2004;16:256–60.
Perimenis P, Karkoulias K, Konstantinopoulos A, et al. Sildenafil versus continuous positive airway pressure for erectile dysfunction in men with obstructive sleep apnea: a comparative study of their efficacy and safety and the patient's satisfaction with treatment. Asian J Androl 2007; 9:259–64.
Li X, Dong Z, Wan Y, Wang Z. Sildenafil versus continuous positive airway pressure for erectile dysfunction in men with obstructive sleep apnea: a meta-analysis. The Aging Male 2010;13:82–6. http://dx.doi.org/10.3109/13685530903406789
Harsch IA, Schahin SP, Brückner K, et al. The effect of continuous positive airway pressure treatment on insulin sensitivity in patients with obstructive sleep apnoea syndrome and type 2 diabetes. Respiration 2004;71:252–9.
Brooks B, Cistulli PA, Borkman M, et al. Obstructive sleep apnea in obese noninsulin-dependent diabetic patients: effect of continuous positive airway pressure treatment on insulin responsiveness. J Clin Endocrinol Metab 1994;79:1681–5.
Iftikhar IH, Hoyos CM, Phillips CL, Magalang UJ. Meta-analyses of the association of sleep apnea with insulin resistance, and the effects of CPAP on HOMA-IR, adiponectin, and visceral adipose fat. J Clin Sleep Med 2015;11:475–85. http://dx.doi.org/10.5664/jcsm.4610
Chen L, Pei JH, Chen HM. Effects of continuous positive airway pressure treatment on glycaemic control and insulin sensitivity in patients with obstructive sleep apnoea and type 2 diabetes: a meta-analysis. Arch Med Sci 2014;10:637–42. http://dx.doi.org/10.5114/aoms.2014.44854
Yang D, Liu Z, Yang H. The impact of effective continuous positive airway pressure on homeostasis model assessment insulin resistance in non-diabetic patients with moderate to severe obstructive sleep apnea. Diabetes Metab Res Rev 2012;28:499–504.
Babu AR, Herdegen J, Fogelfeld L, Shott S, Mazzone T. Type 2 diabetes, glycemic control, and continuous positive airway pressure in obstructive sleep apnea. Arch Intern Med 2005;165:447–52.
Pallayova M, Donic V, Tomori Z. Beneficial effects of severe sleep apnea therapy on nocturnal glucose control in persons with type 2 diabetes mellitus. Diabetes Res Clin Pract 2008;81:e8–11 http://dx.doi.org/10.1016/j.diabres.2008.03.012
Shpirer I, Rapoport M, Stav D, Elizur A. Normal and elevated HbA1C levels correlate with severity of hypoxemia in patients with obstructive sleep apnea and decrease following CPAP treatment. Sleep Breath 2012;16:461–6. http://dx.doi.org/10.1007/s11325-011-0525-x
Myhill PC, Davis WA, Peters KE, Chubb SAP, Hillman D, Davis TME. Effect of continuous positive airway pressure therapy on cardiovascular risk factors in patients with type 2 diabetes and obstructive sleep apnea. J Clin Endocrinol Metab 2012;97:4212–18. http://dx.doi.org/10.1210/jc.2012-2107
Hassaballa HA, Tulaimat A, Herdegen JJ, Mokhlesi B. The effect of continuous positive airway pressure on glucose control in diabetic patients with severe obstructive sleep apnea. Sleep Breath 2005;9:176–80.
West SD, Nicoll DJ, Wallace TM, Matthews DR, Stradling JR. Effect of CPAP on insulin resistance and HbA1c in men with obstructive sleep apnoea and type 2 diabetes. Thorax 2007;62:969–74.
Shaw JE, Punjabi NM, Naughton MT et al. The effect of treatment of obstructive sleep apnea on glycemic control in type 2 diabetes. Am J Respir Crit Care Med 2016;194(4):486-92. http://dx.doi.org/10.1164/rccm.201511-2260OC.
Martínez-Cerón E, Barquiel B, Bezos AM et al. Effect of continuous positive airway pressure on glycemic control in patients with obstructive sleep apnea and type 2 diabetes. A Randomized Clinical Trial. Am J Respir Crit Care Med 2016;194(4):476-85. http://dx.doi.org/10.1164/rccm.201510-1942OC.
Feng Y, Zhang Z, Dong ZZ. Effects of continuous positive airway pressure therapy on glycaemic control, insulin sensitivity and body mass index in patients with obstructive sleep apnoea and type 2 diabetes: a systematic review and meta-analysis. Npj Primary Care Respir Med 2015;25:15005. http://dx.doi.org/10.1038/npjpcrm.2015.5.
Grimaldi D, Beccuti G, Touma C, Van Cauter E, Mokhlesi B. Association of obstructive sleep apnea in REM sleep with reduced glycemic control in type 2 diabetes: therapeutic implications. Diabetes Care 2014;37: 355–63. http://dx.doi.org/10.2337/dc13-0933
Tahrani AA. Comment on Guest et al. Clinical outcomes and cost effectiveness of continuous positive airway pressure to manage obstructive sleep apnea in patients with type 2 diabetes in the U.K. Diabetes Care 2014;37:e200-e201. http://dx.doi.org/10.2337/dc14-1000
Hu X, Fan J, Chen S, Yin Y, Zrenner B. The role of continuous positive airway pressure in blood pressure control for patients with obstructive sleep apnea and hypertension: a meta-analysis of randomized controlled trials. J Clin Hypertens 2015;17:215–22. http://dx.doi.org/10.1111/jch.12472
Pedrosa RP, Drager LF, de Paula LKG, Amaro ACS, Bortolotto LA, Lorenzi-Filho G. Effects of OSA treatment on BP in patients with resistant hypertension: a randomized trial. Chest 2013;144:1487–94. http://dx.doi.org/10.1378/chest.13-0085
Martínez-García M, Capote F, Campos-Rodríguez F. Effect of CPAP on blood pressure in patients with obstructive sleep apnea and resistant hypertension: The HIPARCO randomized clinical trial. JAMA 2013;310: 2407–15. http://dx.doi.org/10.1001/jama.2013.281250
Pépin JL, Tamisier R, Barone-Rochette G, Launois SH, Lévy P, Baguet JP. Comparison of continuous positive airway pressure and valsartan in hypertensive patients with sleep apnea. Am J Respir Crit Care Med 2010;182:954–60. http://dx.doi.org/10.1164/rccm.200912-1803OC
Prasad B, Carley DW, Krishnan JA, Weaver TE, Weaver FM. Effects of positive airway pressure treatment on clinical measures of hypertension and type 2 diabetes. J Clin Sleep Med 2012;8:481–7. http://dx.doi.org/10.5664/jcsm.2136
Barbé F, Durán-Cantolla J, Sánchez-de-la-Torre M. Effect of continuous positive airway pressure on the incidence of hypertension and cardiovascular events in nonsleepy patients with obstructive sleep apnea: a randomized controlled trial. JAMA 2012;307:2161–8. http://dx.doi.org/10.1001/jama.2012.4366
Nadeem R, Singh M, Nida M, et al. Effect of CPAP treatment for obstructive sleep apnea hypopnea syndrome on lipid profile: a meta-regression analysis. J Clin Sleep Med 2014;10:1295–302. http://dx.doi.org/10.5664/jcsm.4282
Xu H, Yi H, Guan J, Yin S. Effect of continuous positive airway pressure on lipid profile in patients with obstructive sleep apnea syndrome: a meta-analysis of randomized controlled trials. Atherosclerosis 2014; 234:446–53. http://dx.doi.org/10.1016/j.atherosclerosis.2014.03.034
Mason RH, Kiire CA, Groves DC, et al. Visual improvement following continuous positive airway pressure therapy in diabetic subjects with clinically significant macular oedema and obstructive sleep apnoea: proof of principle study. Respiration 2012;84:275–82. http://dx.doi.org/10.1159/000334090
Diamanti C, Manali E, Ginieri-Coccossis M, et al. Depression, physical activity, energy consumption, and quality of life in OSA patients before and after CPAP treatment. Sleep Breath 2013;17:1159–68. http://dx.doi.org/10.1007/s11325-013-0815-6
Bjornsdottir E, Keenan BT, Eysteinsdottir B, et al. Quality of life among untreated sleep apnea patients compared with the general population and changes after treatment with positive airway pressure. J Sleep Res 2015;24:328–38. http://dx.doi.org/10.1111/jsr.12262
Published
Issue
Section
License
Publish & Transfer of Copyright Agreement
For the mutual benefit and protection of the Author and the Journal Owner/Publisher it is necessary that the Author provides formal written Consent to Publish and Transfer of Copyright before publication of the Work.
